Literature DB >> 1711789

Limited cardiac preload reserve in conscious cirrhotic rats.

A C Inglés1, I Hernández, J García-Estañ, T Quesada, L F Carbonell.   

Abstract

In conscious rats with experimental cirrhosis without ascites, we have studied whether there is a limited cardiac preload reserve by performing cardiac output (CO) curves. CO was determined by thermodilution at basal, 5, 7.5, and 10 cmH2O of right atrial pressure (RAP). RAP was elevated by dextran infusion (1 ml/min iv, 30 min). CO curves were performed by plotting changes in CO with changes in RAP. In the basal state, cirrhotic rats showed a hyperdynamic circulation defined by increased CO and stroke volume, decreased total peripheral resistances, and normotension without changes in heart rate. Blood volume was also elevated in cirrhotic rats compared with the control animals. Between the limits of RAP studied, the CO curve of control rats presented a typical ascending limb. In contrast, the CO curve of the cirrhotic animals showed first an ascending shifted upward limb and afterward a descending limb. These alterations were accompanied by changes in the inotropic state as measured as left ventricular (LV) peak dP/dt in hexamethonium-pretreated animals submitted to the same volume loads described above. With the same increases in RAP, LV dP/dt changed, in every group, in a manner similar to CO. The results of the present study indicate that cirrhotic rats with high blood volume and hyperdynamic circulation show, in the steady state, a limited preload reserve. The partial utilization of the preload reserve can make the cirrhotic heart unable to modulate cardiac performance with changes in loading conditions, thus determining a state of heart failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711789     DOI: 10.1152/ajpheart.1991.260.6.H1912

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Origins of cardiac dysfunction in cirrhosis.

Authors:  W Jiménez; V Arroyo
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 2.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

3.  Prevalence and clinical presentation of cirrhotic cardiomyopathy: A single centre experience from southern India.

Authors:  Ravi Bokarvadia; Mayank Jain; Chandankumar Kedarisetty; Joy Varghese; Jayanthi Venkataraman
Journal:  Indian J Gastroenterol       Date:  2019-05-21

4.  Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.

Authors:  M Huonker; Y O Schumacher; A Ochs; S Sorichter; J Keul; M Rössle
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

5.  Cirrhotic cardiomyopathy.

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2008-11-11       Impact factor: 6.047

6.  Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.

Authors:  Seyed Ali Gaskari; Hongqun Liu; Leila Moezi; Yang Li; Soon Koo Baik; Samuel S Lee
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 7.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 8.  Cardiovascular changes in cirrhosis: pathogenesis and clinical implications.

Authors:  Waleed K Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2010 Jul-Sep       Impact factor: 2.485

Review 9.  Cirrhotic cardiomyopathy.

Authors:  Soon Koo Baik; Tamer R Fouad; Samuel S Lee
Journal:  Orphanet J Rare Dis       Date:  2007-03-27       Impact factor: 4.123

10.  Cardiac dysfunction in cirrhotic portal hypertension with or without ascites.

Authors:  Sunil Dadhich; Amitava Goswami; Vinit Kumar Jain; Ankur Gahlot; Ganaraj Kulamarva; Narendra Bhargava
Journal:  Ann Gastroenterol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.